col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


23 Ergebisse       Seite 1

 [1] 
Elsevier: Biologicals
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―23 Molecular characteristics of feline coronavirus in South Korea, 2016-2023 Sung-Hee Kim, Kyoung-Ki Lee, Ilseob Lee, Go-Eun Shin, Ji-Ung Jang, Yoon-A Joo, et al. (+4)
2 [GO] 2025―Apr―03 Regulatory changes during the Covid-19 pandemic: A comparative review of the European Union and Brazilian regulations for biological and biotechnological products Priscila Leone Nassur, Fernanda Borges de Almeida, Fernando Lucas Primo
3 [GO] 2024―Jun―25 COVID-19: A case for plasma derived natural anticoagulants? Rainer Seitz, Lutz Gürtler, Wolfgang Schramm
4 [GO] 2024―Mai―14 Design and computational evaluation of a novel multi-epitope hybrid vaccine against monkeypox virus: Potential targets and immunogenicity assessment for pandemic preparedness Allah Rakha Yaseen, Muhammad Suleman, Aqsa Jabeen, Laiba Nezami, Abdul Salam Qadri, Ayesha Arif, et al. (+4)
5 [GO] 2024―Mrz―15 pH inactivation of SARS-CoV-2 and SARS-CoV in virus spiked protein A eluates from a mAb purification process Hannah Limburg, Marie Schwerdtner, Eileen Wilson, Bernhard Roth, Jean-Pol Cassart, Anke-Dorothee Werner, et al. (+3)
6 [GO] 2023―Dez―14 An antibody-free evaluation of an mRNA COVID-19 vaccine Paul J. Branham, Hans C. Cooper, Yulanda M. Williamson, Fabio N. Najjar, William J.H. Sutton, Carrie L. Pierce-Ruiz, et al. (+2)
7 [GO] 2023―Nov―16 Enabling the evaluation of COVID-19 vaccines with correlates of protection Arnaud Marchant, Pierre Van Damme, Stanley Plotkin, Pieter Neels, Maria Cristina Cassetti, Jakob Cramer, et al. (+5)
8 [GO] 2023―Okt―20 Corrigendum to “Comparison of Astra Zeneca and sinopharm vaccines as boosters in protection against COVID-19 infection” [Biologicals 82 (2023) 101668] Arash Letafati, Nooshin Eyvazzadeh, Amirhossein Gharehkhani, Ayeh Khorshidian, Siavash Chalabiani, Elnaz Khodadoust Soufiani, et al. (+7)
9 [GO] 2023―Okt―05 Emergence of SARS-CoV-2 variant of interest B.1.525 (Eta) in Bangladesh Barna Goswami, Md Murshed Hasan Sarkar, Shahina Akter, Tanjina Akhtar Banu, Iffat Jahan, Md Saddam Hossain, et al. (+9)
10 [GO] 2023―Okt―04 Development of an optimized RT-LAMP test for the detection of SARS-CoV-2 Navid Momenifar, Mohammad Pirouzfar, Zohreh Hashemian, Abdolreza Daneshvar Amoli
11 [GO] 2023―Mai―03 Rapid production and free distribution of a synthetic RNA material to support SARS-CoV-2 molecular diagnostic testing Megan H. Cleveland, Erica L. Romsos, Carolyn R. Steffen, Nathan D. Olson, Stephanie L. Servetas, William G. Valiant, Peter M. Vallone
12 [GO] 2023―Mrz―13 Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection Arash Letafati, Nooshin Eyvazzadeh, Amirhossein Gharehkhani, Ayeh Khorshidian, Siavash Chalabiani, Elnaz Khodadoust Soufiani, et al. (+7)
13 [GO] 2022―Sep―13 Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients Shahrzad Hamldar, Seyed Jalal Kiani, Majid Khoshmirsafa, Javid Sadri Nahand, Hamed Mirzaei, AliReza Khatami, et al. (+5)
14 [GO] 2022―Sep―02 Molecular characterization and sequecing analysis of SARS-CoV-2 genome in Minas Gerais, Brazil Giulia Magalhães Ferreira, Ingra Morales Claro, Victória Riquena Grosche, Darlan Cândido, Diego Pandeló José, Esmenia Coelho Rocha, et al. (+7)
15 [GO] 2022―Aug―31 A collaborative study to establish the national standard for SARS-CoV-2 RNA nucleic acid amplification techniques (NAAT) in Taiwan Po-Lin Lin, Ming-Sian Wu, Po-Chi Wu, Hsin-Mei Chen, Yi-Hsuan Peng, Jia-Chuan Hsu, Der-Yuan Wang
16 [GO] 2022―Jun―02 Accelerated national lot release on COVID-19 vaccines in Korea Misook Yang, Naery Lee, Jung Hun Ju, In-Sook Park, Jin Tae Hong, Ho Jung Oh
17 [GO] 2022―Jan―14 An overview of non-clinical safety studies in current Turkish regulations for the development of COVID-19 vaccines Sadi S. Ozdem
18 [GO] 2021―Nov―17 Emerging genetic diversity of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) alters its B-cell epitopes Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad
19 [GO] 2021―Sep―03 Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development? J. Vandeputte, P. Van Damme, J. Neyts, J.C. Audonnet, M. Baay, P. Neels
20 [GO] 2020―Nov―20 Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic Marc Baay, Bruno Lina, Arnaud Fontanet, Arnaud Marchant, Melanie Saville, Philippe Sabot, et al. (+2)
21 [GO] 2020―Aug―29 SARS-CoV-2 and the safety margins of cell-based biological medicinal products Jens Modrof, Astrid Kerschbaum, Maria R. Farcet, Daniela Niemeyer, Victor M. Corman, Thomas R. Kreil
22 [GO] 2020―Aug―15 SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues Marc Baay, Pieter Neels
23 [GO] 2020―Jun―23 SARS-CoV-2: Virology, epidemiology, immunology and vaccine development Marc Baay, Bruno Lina, Arnaud Fontanet, Arnaud Marchant, Melanie Saville, Philippe Sabot, et al. (+3)
 [1] 

23 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec